The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their pitch.
The Trump administration raised hopes of a speedy process for nursing homes and assisted living facilities. Patience is wearing thin.
The company agreed to deliver the additional doses of its coronavirus vaccine by the end of July, helping address a looming shortage.
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
The company could provide at least tens of millions of additional doses of a coronavirus vaccine under an agreement that would give it better access to the supplies it needs to expand manufacturing.
A large-scale public education campaign, delayed by false starts and investigations, will get off the ground just as the coronavirus vaccine becomes available to high-risk Americans.
As cases surge and hospital beds fill up, federal officials said a vaccine could be distributed to as many as 24 million people by mid-January.
When President Trump quit the health organization, he left a list of seven demands on the table. Here they are.
Yes, the coronavirus can be spread over cocktails and dinners. But these get-togethers do not account for the huge rise in cases seen now, the data show.
A new rule would base the price Medicare pays for certain drugs on the lowest price paid among similar countries. But a rushed process means legal challenges are likely.
A proposal announced by President Trump last month was to send older Americans $200 discount cards to offset prescription costs. It’s not going to happen before the election, and maybe not ever.
President Trump’s health secretary voiced optimism on Sunday that vaccines and treatments would soon save the day, but governors and experts issued bleak warnings about the public letting down its guard.
The F.D.A. proposed stricter guidelines for emergency approval of a coronavirus vaccine, but the White House chief of staff objected to provisions that would push approval past Election Day.
New details of how the president has demanded faster action from health agencies help explain the intensifying concern that he could demand pre-Election Day approval of a vaccine.
The agency’s chief spokeswoman, Emily Miller, was removed from her position just 11 days into the job. And the contract was terminated of a consultant who had advised the F.D.A. chief to correct misleading claims about plasma’s benefits.
Many experts — including a scientist who worked on the Mayo Clinic study — were bewildered about where a key statistic came from.
The Department of Health and Human Services told hospitals in April that reporting to the vendor, TeleTracking Technologies, was a “prerequisite to payment.”
A new advisory board, appointed by the Trump administration, recommended that the health secretary reject funding for virtually every fetal tissue research project it considered.
President Trump prefers a robust relationship with authoritarian China to one with democratic Taiwan. But other American officials aim to strengthen U.S.-Taiwan ties.
An administration shift is putting a burden on hospitals and undercutting the integrity of data on the pandemic, current and former members of a federal advisory panel said.
The competition among his cabineteers is fierce.
The trip by Alex M. Azar II, a rare high-level U.S. visit, is being billed as an opportunity to highlight Taiwan’s success in battling the coronavirus pandemic.
Operation Warp Speed has moved along at a rapid clip. But some people involved in the approval process fear pressure to deliver an October surprise for President Trump.
The White House is eager to project progress, but the public-private partnership it has created still faces scientific hurdles, internal tensions and questions from Congress.
Just don’t call him Tweety.
A group of 77 Nobel laureates wants the U.S. government to review a grant cancellation for research in China directly related to preventing pandemics.
Dr. Rick Bright testified that he made early appeals that the Trump administration prepare for the coronavirus. President Trump and his health secretary snapped back.
The group had provided President Trump a backdrop for his daily briefings while working to coordinate the government response to the pandemic.
The president wants a coronavirus vaccine widely available by the end of the year, even though his public health experts say it will take at least a year to 18 months.
Alex M. Azar II has long been seen as a difficult personality in President Trump’s cabinet, but the pandemic has exacerbated personal clashes, putting him on thin ice.
The president and senior officials manipulated Americans and played down the severity of the pandemic.
A cult of personality is no match for a pandemic.
The loyalty of the longtime Trump adviser Michael Caputo helped him secure a post as the top public affairs official at the Health and Human Services Department during the pandemic.
An examination reveals the president was warned about the potential for a pandemic but that internal divisions, lack of planning and his faith in his own instincts led to a halting response.
Aggressive screening might have helped contain the coronavirus in the United States. But technical flaws, regulatory hurdles and lapses in leadership let it spread undetected for weeks.
The administration’s response to the coronavirus has repeatedly matched public health experts against a hesitant White House, where worry of panic dominates.
Despite efforts by President Trump and others to reassure the public that tests are getting disseminated quickly, several states, doctors and patients complained that access was limited.
Appearing before cameras sometimes multiple times a day to talk about the outbreak, the president has offered rosy assessments and unproven or even false assertions.